These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 34997835)

  • 21. Pharmacokinetics, tolerability, and safety of the single oral administration of AGSAV301 vs Exforge: a randomized crossover study of healthy male volunteers.
    Choi HY; Kim YH; Kim MJ; Noh YH; Lee SH; Bae KS; Lim HS
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):63-72. PubMed ID: 24174172
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pharmacokinetics of rosuvastatin/olmesartan fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Son H; Roh H; Lee D; Chang H; Kim J; Yun C; Park K
    Clin Ther; 2013 Jul; 35(7):915-22. PubMed ID: 23810276
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparative pharmacokinetics of a montelukast/levocetirizine fixed-dose combination chewable tablet versus individual administration of montelukast and levocetirizine after a single oral administration in healthy Korean male subjects
.
    Moon SJ; Yu KS; Jung J; Kim YI; Kim MG
    Int J Clin Pharmacol Ther; 2020 Jun; 58(6):354-362. PubMed ID: 32271144
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetics of a fixed-dose combination of mitiglinide and metformin versus concurrent administration of individual formulations in healthy subjects: a randomized, open-label, two-treatment, two-period, two-sequence, single-dose, crossover study.
    Jung JA; Kim JR; Kim SR; Kim TE; Lee SY; Ko JW; Huh W
    Clin Drug Investig; 2012 Dec; 32(12):799-804. PubMed ID: 23100167
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetic properties and bioequivalence of 2 formulations of valsartan 160-mg tablets: A randomized, single-dose, 2-period crossover study in healthy Korean male volunteers.
    Kim JE; Ki MH; Yoon IS; Cho HJ; Kim RS; Tae Kim G; Kim DD
    Clin Ther; 2014 Feb; 36(2):273-9. PubMed ID: 24529292
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bioequivalence for a Fixed-Dose Combination Formulation of Bazedoxifene and Cholecalciferol Compared With the Corresponding Single Entities Given Together.
    Yun JN; Kan HS; Yeun JS; Kim JH; Lee M; Kim N; Oh TY; Nam SK; Choi YS; Kwon IS; Hoe KL; Hong JH
    Clin Pharmacol Drug Dev; 2021 Aug; 10(8):850-858. PubMed ID: 34190419
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacokinetics and bioequivalence study of three oral formulations of valsartan 160 mg: a single-dose, randomized, open-label, three-period crossover comparison in healthy Indian male volunteers.
    Iqbal M; Khuroo A; Batolar LS; Tandon M; Monif T; Sharma PL
    Clin Ther; 2010 Mar; 32(3):588-96. PubMed ID: 20399995
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Evaluation of Pharmacokinetic Interactions Between the New SGLT2 Inhibitor SHR3824 and Valsartan in Healthy Chinese Volunteers.
    Huang Y; Liu R; Wang Y; Liu G; Wang C; Chen X; Jia Y; Shen J
    Clin Ther; 2022 Jul; 44(7):945-956. PubMed ID: 35778161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacokinetic and bioequivalence study comparing a fimasartan/rosuvastatin fixed-dose combination with the concomitant administration of fimasartan and rosuvastatin in healthy subjects.
    Kang WY; Seong SJ; Ohk B; Gwon MR; Kim BK; Cho S; Shim WS; Lee KT; Kim EH; Yang DH; Lee HW; Yoon YR
    Drug Des Devel Ther; 2018; 12():3607-3615. PubMed ID: 30464392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Comparison of the pharmacokinetics and tolerability of montelukast/levocetirizine administered as a fixed-dose combination and as separate tablets.
    Kim S; Ko JW; Kim JR
    Int J Clin Pharmacol Ther; 2018 Sep; 56(9):443-450. PubMed ID: 30021691
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A fixed-dose combination tablet of gemigliptin and metformin sustained release has comparable pharmacodynamic, pharmacokinetic, and tolerability profiles to separate tablets in healthy subjects.
    Park SI; Lee H; Oh J; Lim KS; Jang IJ; Kim JA; Jung JH; Yu KS
    Drug Des Devel Ther; 2015; 9():729-36. PubMed ID: 25678778
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Results of a single-center, single-dose, randomized-sequence, open-label, two-way crossover bioequivalence study of two formulations of valsartan 160-mg tablets in healthy volunteers under fasting conditions.
    Spínola AC; Almeida S; Filipe A; Neves R; Trabelsi F; Farré A
    Clin Ther; 2009 Sep; 31(9):1992-2001. PubMed ID: 19843489
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fixed-dose combination tablet of repaglinide and metformin is bioequivalent to concomitantly administered individual tablets of repaglinide and metformin : randomized, single-blind, three-period crossover study in healthy subjects.
    Hoelscher D; Chu PL; Lyness W
    Clin Drug Investig; 2008; 28(9):573-82. PubMed ID: 18666804
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Fixed-Dose Combination Of Gemigliptin And Rosuvastatin Exhibits Similar Pharmacokinetics, Pharmacodynamics, And Safety Compared To That Of A Loose Combination In Healthy Subjects.
    Kim E; Park KR; Jang IJ; Yu KS; Lee S
    Drug Des Devel Ther; 2019; 13():3879-3885. PubMed ID: 32009778
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacokinetic and bioequivalence study of a fixed-dose combination of amlodipine besylate and rosuvastatin calcium compared to co-administration of separate tablets in healthy Korean subjects
.
    Park JS; Jeon JY; Kim MG
    Int J Clin Pharmacol Ther; 2019 Dec; 57(12):612-622. PubMed ID: 31549624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacokinetics of a telmisartan/rosuvastatin fixed-dose combination: a single-dose, randomized, open-label, 2-period crossover study in healthy Korean subjects.
    Chae DW; Son M; Kim Y; Son H; Jang SB; Seo JM; Nam SY; Park K
    Int J Clin Pharmacol Ther; 2015 Oct; 53(10):883-9. PubMed ID: 26329347
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparative pharmacokinetics of a fixed-dose combination vs concomitant administration of telmisartan and S-amlodipine in healthy adult volunteers.
    Oh M; Park SE; Ghim JL; Choi YK; Shim EJ; Shin JG; Kim EY
    Drug Des Devel Ther; 2017; 11():3543-3550. PubMed ID: 29270003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacokinetic and pharmacodynamic drug interaction between rosuvastatin and valsartan in healthy subjects.
    Jung JA; Lee SY; Kim JR; Ko JW; Jang SB; Nam SY; Huh W
    Drug Des Devel Ther; 2015; 9():745-52. PubMed ID: 25767372
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bioequivalence and food effect of a fixed-dose combination of macitentan and tadalafil: Adaptive design in the COVID-19 pandemic.
    Csonka D; Fishman V; Natarajan J; Stieltjes H; Armas D; Dishy V; Perez Ruixo JJ
    Pharmacol Res Perspect; 2021 Oct; 9(5):e00846. PubMed ID: 34624174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pharmacokinetics and bioequivalence of fixed-dose combination of candesartan cilexetil/amlodipine besylate (16/10 mg) versus coadministration of individual formulations in healthy subjects.
    Lee HW; Kang WY; Jung W; Gwon MR; Yang DH; Kim EH; Cho K; Yoon YR; Seong SJ
    Transl Clin Pharmacol; 2020 Jun; 28(2):92-101. PubMed ID: 32656160
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.